The article discusses issues concerning risk/benefit assessment of veterinary medicinal products. The evidence for the benefit of medicine for animal health and wealth needs to be present in the application dossier. The risk/benefit balance needs to be assessed by risk management, which includes establishment of the conditions of the authorization.